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Purpose. Patients with a reported β-lactam allergy (BLA) are often given
alternative perioperative antibiotic prophylaxis, increasing risk of surgical
site infections (SSIs), acute kidney injury (AKI), and Clostridioides difficile
infection (CDI). The purpose of this study was to implement and evaluate
a pharmacist-led BLA clarification interview service in the preoperative
setting.
Methods. A pharmacist performed BLA clarification telephone interviews
before elective procedures from November 2018 to March 2019. On the
basis of allergy history and a decision algorithm, first-line preoperative
antibiotics, alternative antibiotics, or allergy testing referral was recommended. The pharmacist intervention (PI) group was compared to a standard of care (SOC) group who underwent surgery from November 2017 to
March 2018.
Results. Eighty-seven patients were included, with 50 (57%) and 37
(43%) in the SOC and PI groups, respectively. The most common surgeries
included orthopedic surgery in 41 patients (47%) and neurosurgery in 17
patients (20%). In the PI group, all BLA labels were updated after interview.
Twenty-three patients were referred for allergy testing, 12 of the 23 (52%)
completed BLA testing, and penicillin allergies were removed for 9 of the
12 patients. Overall, 28 of the 37 (76%) pharmacy antibiotic recommendations were accepted. Cefazolin use significantly increased from 28% to
65% after the intervention (P = 0.001). SSI occurred in 5 (10%) patients in
the SOC group and no patients in the PI group (P = 0.051). All of these SSIs
were associated with alternative antibiotics. Incidence of AKI and CDI was
similar between the groups. No allergic reactions occurred in either group.
Conclusion. Implementation of a pharmacy-driven BLA reconciliation
significantly increased β-lactam preoperative use without negative safety
outcomes.
Keywords: β-lactam allergy, elective surgical procedures, perioperative
care, pharmacists, preoperative care, surgical wound infection
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enicillin allergies are reported in
10% of the general population;
however, 90% to 99% of these patients can safely receive β-lactams.1
First-line antibiotics for surgical infection prophylaxis include cefazolin or
cefoxitin, but patients with a reported
β-lactam allergy (BLA) are more likely
to receive alternative antibiotics such
as vancomycin, clindamycin, or gentamicin.2,3 These alternatives increase the
risk of Clostridioides difficile infection
(CDI) and acute kidney injury (AKI)
and the potential to develop antibiotic
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resistance.3 One study demonstrated
that patients with reported penicillin
allergies had 50% increased odds of
developing a surgical site infection
(SSI), attributable to receiving alternative antimicrobial prophylaxis.3 SSIs are
associated with short- and long-term
patient harm such as rehospitalization,
prolongment of hospital length of stay
(LOS) by 7 to 10 days, and lower quality
of life, infection-related complications,
a mortality rate of 3%, and an estimated
cost of over $25,000 and penalties in procedure reimbursement.4-6
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Methods
Study design and patient
population. This was a single-center,
quasi-experimental study at a large
academic medical center with about
1,200 elective surgical cases performed
monthly. Select patients meeting criteria were seen at our institution’s
perioperative optimization clinic for
clearance about 2 to 3 weeks before surgery. These patients included higherrisk patients such as those who had a
recent ST-elevation myocardial infarction or cardiovascular event, patients on
home oxygen, patients with end-stage
renal disease or end-stage liver disease,
and patients who were fully dependent.
In addition, patients undergoing highand intermediate-risk procedures were
seen in the perioperative optimization
clinic, including patients undergoing
aortic, open vascular, or open thoracic surgeries, surgeries expected to
last more than 4 hours, surgeries with
large fluid shifts anticipated, neurosurgery, or intraabdominal, orthopedic, or
ear, nose, and throat surgery. Patients
were included if they had a BLA, a perioperative optimization clinic appointment, and a surgery where a β-lactam
antibiotic was considered first for
SSI prophylaxis.11 Exclusion criteria

2
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included non-English speakers, pregnancy, and transplant surgery. The
study was approved by the institution’s
investigational review board with
waiver of consent.
Intervention. Before implementation, pharmacy met with key stakeholders from infectious disease, surgery,
anesthesiology, and allergy for input
and approval of all intervention material. These groups along with operative
nursing received thorough education of
the algorithm and intervention before
implementation. From November 2018
to March 2019, a pharmacist performed
BLA clarification telephone interviews.
Patients were identified by screening for
patients who met the inclusion criteria
using the perioperative optimization
clinic schedule. The telephone interview took place about 1 week before the
patient’s clinic appointment to allow
about 1 month to follow up with the allergy clinic, if recommended.
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The interview reviewed the reaction, timing, and tolerance of other
β-lactam antibiotics (Appendix A). On
the basis of allergy history and the decision algorithm, first-line antibiotics,
alternative antibiotics, or an electronic
allergy testing referral was recommended and documented in the electronic medical record (EMR) (Figure 1).
Antibiotic recommendations followed institutional guidelines, which
are consistent with national surgical
infection prophylaxis guidelines.3
Vancomycin was added to regimens
if the patient had institution-specified
methicillin-resistant Staphylococcus
aureus (MRSA) risk factors.11 The allergy label in the EMR was updated
with details discussed during the interview (Appendix A). Patients referred
to allergy testing followed up with
one of the institution’s allergy clinics
to undergo a penicillin skin test and
oral challenge with amoxicillin. BLA
labels were removed if deemed appropriate by an allergist. The surgeon was
notified of the intervention and recommendations via EMR documentation
(Appendix B). The surgical team ordered preoperative antibiotics before
the procedure. Patients who received
the pharmacist intervention (PI) from
November 2018 to March 2019 were
compared to surgical patients meeting
inclusion and exclusion criteria between November 2017 and March 2018
as a historical standard of care (SOC).
Endpoints. The primary endpoint
was the use of β-lactams preoperatively. Secondary endpoints included
clinical outcomes and process measures. Clinical outcomes included
30-day SSI and CDI, AKI, allergic reactions, and LOS. SSI was defined according to the Centers for Disease
Control and Prevention definitions
at day 30 after surgery.12 CDI was defined as presence of diarrhea and either a positive stool test result for the
presence of C. difficile or its toxins or
colonoscopic or histopathologic findings of pseudomembranous colitis.13
Allergic reaction was defined as a type
I hypersensitivity reaction, cytotoxic reaction, serum sickness, drug reaction
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National guidelines recommend
clarifying all BLAs, but many are
unclarified before giving alternative
antibiotics in the perioperative setting.2
Previous studies have described successful allergy interventions such as
BLA interviews, cross-reactivity charts,
β-lactam skin testing, and oral β-lactam
antibiotic challenge in the preoperative
setting.7-10 These studies showed significant increases in β-lactam antibiotic
prophylaxis use and operating room
time saved when the prolonged infusion time of vancomycin was avoided.
Pharmacists are well trained and
positioned to optimize preoperative
antibiotic selection to potentially decrease intraoperative time, adverse effects, and risk of SSI. The purpose of this
study was to implement and evaluate a
pharmacist-led BLA interview to optimize surgical infection prophylaxis.

PREOPERATIVE Β-LACTAM ALLERGY CLARIFICATION
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Figure 1. Reported β-lactam allergy clarification interview algorithm. An algorithm for the management of a surgical patient based on a comprehensive allergy history interview. BLA indicates β-lactam allergy; DRESS, drug reaction with
eosinophilia and systemic symptoms; IgE, immunoglobulin E; SCAR, severe cutaneous adverse reaction.

order, was used to potentially control
for maturation bias between the 2 study
time periods.
Analysis. Continuous variables
were compared using Mann-Whitney
tests or t tests, as appropriate.
Categorical data were compared using
χ2 tests. It was estimated that 46 individuals were needed per group for an
effect size of 26% reduction in alternative antibiotics to meet 80% power and
a 2-sided α value of 0.05.7 Data analysis
was performed using SPSS, version 22.0
(IBM Corporation, Armonk, NY).

Results
Study population. Overall, 129
patients were screened for inclusion:
74 patients in the SOC group and 55
patients in the PI group. Fifty patients
AM J HEALTH-SYST PHARM
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were included in the SOC group, and 37
patients were included in the PI group.
The most common reason for exclusion in the SOC group and PI group was
patients not having elective surgery
(n = 10, 14%) and patients unable to be
reached by telephone after 3 attempts
(n = 13, 24%), respectively. Patient
demographics and reported allergy
characteristics are described in Table 1.
There were significantly more patients
undergoing orthopedic surgery and
neurosurgery in the PI group than in
the SOC group. The SOC group had a
greater variety of surgeries as compared
to the PI group, including vascular,
bariatric, and gynecologic surgeries.
Allergy characteristics were similar between the groups. The most common
reported allergen was penicillin (66%
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with eosinophilia and systemic symptoms, severe cutaneous adverse reaction, or toxic epidermal necrolysis
within 7 days of preoperative antibiotic
administration. AKI was defined as an
increase in serum creatinine levels of
0.3 mg/dL or serum creatinine levels
greater than 1.5 times baseline within
4 days of preoperative antibiotic administration.14 LOS was defined as the
time from the day of surgery to the
day of discharge. Process outcomes
included allergy labels updated or removed, recommendations accepted by
the physician, vancomycin doses administered, and time to incision. Time
to incision was defined as the time from
operating room entry to the first incision.8 A nonequivalent dependent variable, sequential compression device
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Table 1. Patient Demographics and Reported Allergy Characteristics
Characteristic

SOC (n = 50)

PI (n = 37)

69 (61-76)

66 (61-73)

Male sex, No. (%)

17 (34)

12 (32)

Caucasian race, No. (%)

33 (67)

19 (51)

19 (38)

22 (60)

Neurosurgery

6 (12)

12 (32)

Urological

4 (8)

1 (3)

Cardiac

1 (2)

2 (5)

Operation type, No. (%)
Orthopedic

Other

20 (40)

0

ASA classification, median (IQR)

3 (3-3)

3 (3-3)

Body mass index, median (IQR)

30 (29-36)

29 (25-34)

Sequential compression device order, No. (%)

48 (96)

36 (97)

33 (66)

23 (61)

Multiple β-lactam antibiotics

7 (14)

4 (12)

First-generation cephalosporin

6 (12)

2 (6)

Other penicillin

3 (6)

8 (21)

Carbapenem

1 (2)

0

Reported allergy drug, No. (%)
Penicillin

Reported drug reaction, No. (%)
Rash

12 (24)

7 (18)

Unknown

11 (22)

8 (21)

Multiple reactions

10 (20)

8 (21)

Hives

3 (6)

6 (15)

Anaphylaxis

5 (10)

2 (6)

Swelling

3 (6)

1 (3)

Gastrointestinal intolerance

4 (8)

2 (6)

Other

2 (4)

3 (9)

Abbreviations: ASA, American Society of Anesthesiologists; IQR, interquartile range; PI,
pharmacist intervention; SOC, standard of care.

vs 61% in the SOC and PI groups, respectively). The most common patientreported drug reactions were rash (34%
vs 18%), unknown reaction (22% vs
21%), and multiple reactions (20% vs
21%) in the 2 groups.
Postintervention allergy outcomes and recommendations. All
37 patients in the PI group had allergy
labels updated, and 23 of them (64%)
were referred to an allergy clinic for
testing. Of the patients who were referred, 13 (57%) followed up with an

4
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allergy clinic a median of 7 days (interquartile range [IQR], 4-9 days) after the
telephone call. The allergy appointment occurred a median of 14 days
(IQR, 13-16 days) before the day of surgery. Of these patients, 9 (69%) passed
the penicillin allergy test, 3 (23%) failed
testing, and 1 (8%) did not receive
testing due to the patient’s decision
to defer allergy testing. Patients who
passed the penicillin allergy test had
the penicillin allergy label removed by
an allergist. Of note, 2 patients had both
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Age, median (IQR), years

a penicillin and cephalosporin allergy,
so only the penicillin allergy label was
removed after passing the allergy test
while the cephalosporin allergy label
remained on the chart.
Overall, the pharmacist recommendations for preoperative antibiotics
were accepted by the surgeon for 28
(76%) of the 37 patients (Figure 2). The
pharmacist recommended cefazolin
in 19 (51%) patients. Seventeen of the
19 patients (89%) received cefazolin
preoperatively. When alternative antibiotics were recommended, alternative antibiotics were given in 11
patients (61%) and cefazolin was given
in 7 patients (39%) without any allergic
reactions.
Preoperative antibiotics and
outcomes. Cefazolin use significantly
increased from 28% (14/50) to 65%
(24/37) after the intervention (P = 0.001;
Table 2). The most common preoperative regimen in the SOC group was
clindamycin plus gentamicin (14/50).
In the PI group, cefazolin (12/37) and
cefazolin plus vancomycin (12/37)
were used most commonly. Overall,
vancomycin use increased from use in
19 patients (38%) to use in 22 patients
(59%) (P = 0.047). Vancomycin monotherapy or vancomycin in combination
with alternative antibiotics was used
in 14 (28%) and 10 (27%) patients in
the SOC and PI groups, respectively.
Vancomycin was added to cefazolin
due to presence of a MRSA risk factor
in 5 (10%) and 12 (32%) patients in the
SOC and PI groups. Overall, time to incision decreased by a median of 8 minutes (P = 0.484).
No SSIs occurred in the PI group. In
the SOC group, 5 (10%) SSIs occurred
(P = 0.051), and all were associated
with alternative antibiotic use. AKI occurred in 2 (4%) patients who received
alternative antibiotics preoperatively in
the SOC group. No AKI occurred in the
PI group. One instance of CDI occurred
in a patient who received clindamycin
plus gentamicin in the SOC group, while
there was no incidence of CDI in the PI
group. No allergic reactions occurred in
either group. The LOS was a median of
2 days in each group with an IQR of 2.0
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Figure 2. Pharmacist intervention group antibiotic recommendations. Shown
are pharmacist recommendations for preoperative antibiotics and the antibiotic
administered.

Percentage of Anboics Administered

80%

61%
60%

Alternave anbiocs
administered

89%

40%

Cefazolin administered

20%

39%

0%

Cefazolin recommended
(n=19)

Alternave anbiocs
recommended (n=18)

Table 2. Preoperative Antibiotic Management and Safety Outcomes
Treatment or Outcome

SOC (n = 50) PI (n = 37) P Value

β-lactam antibiotic administered, No. (%)

14 (28)

24 (65)

0.001

Vancomycin administered, No. (%)

19 (38)

22 (59)

0.047

Surgical site infection, No. (%)

5 (10)

0

0.051

Clostridioides difficile infection, No. (%)

1 (2)

0

0.387

Allergic reaction, No. (%)

0

0

Acute kidney injury, No. (%)

2 (4)

0

Length of hospitalization, median (IQR), days

2 (2-4.5)

2 (2-2)

0.746
0.014

Abbreviations: IQR, interquartile range; PI, pharmacist intervention; SOC, standard of care.

to 4.5 days and 2.0 to 2.0 days in the SOC
and PI groups, respectively (P = 0.014).
The nonequivalent dependent variable
of sequential compression device order
was similar between the groups (96% vs
97%, P = 0.761).

Discussion
BLA evaluation before surgery led
to an increase in first-line β-lactam
antibiotic use without negative safety
outcomes. The harms of reported BLA
have been well described in the literature and include increased odds of SSI,
AKI, and CDI.3,4 Although this study
had a smaller sample size, the study
showed similar trends in higher SSI,
AKI, and CDI with alternative antibiotic
use perioperatively. Notably, LOS was

significantly different because there
was a wider range of days of hospitalization in the SOC group than in the PI
group. The success of the intervention
relied on collaboration among the key
stakeholders in the surgical process:
pharmacy, infectious disease, surgery,
and allergy leadership.
This study adds to the growing body
of literature describing BLA clarification interventions in the preoperative
setting. One of the challenges of BLA
clarification is the lack of ownership
of the allergy label. In previous literature, various disciplines have been described as taking responsibility for the
BLA clarification process, including
pharmacy, nurses, allergists, and infectious disease physicians.7,8 Pharmacists
AM J HEALTH-SYST PHARM
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are well equipped to perform BLA clarification interviews and assess BLA in
relation to cross-reactivity of β-lactams,
severity of reaction, and prior antibiotic
use. This study highlights the importance of the pharmacist’s role in BLA
clarification interviews and describes
another service for pharmacy.
Although this study utilized a
pharmacist to carry out the intervention, we recognize a potential role for
pharmacy technicians and student
pharmacists in this area. Previous
studies successfully trained medication history pharmacy technicians
and student pharmacists to conduct
allergy histories.15-17 Similarly, with
the proper training and pharmacist
oversight, these pharmacy personnel
could be trained to conduct telephone
allergy history interviews. This possibility would allow both pharmacy
technicians and student pharmacists
to work at the top of their licensure
and decrease the workload of pharmacists in a cost-effective manner.
Additionally, this unique role could
increase recruitment and retention of
pharmacy technicians within health
systems.
Various processes for allergy
clarification in the perioperative setting have been described, including
any combination of BLA interviews,
penicillin skin testing, and oral challenge.7,8 Our intervention involves a
process where all patients receive a
BLA clarification telephone interview
and the pharmacist then determines
whether preoperative antibiotics can
be recommended on the basis of the
interview alone. If not, the pharmacist can refer the patient for a formal
allergy evaluation before surgery,
including a penicillin skin test and
oral challenge, directly through the
EMR. This allows a proportion of patients to avoid a separate visit to the
allergy clinic if the interview alone can
guide antibiotic prophylaxis.
We identified suboptimal patient
follow-up with allergy clinics. One of
the reasons for the lack of follow-up
was not having an allergy clinic in the
same location as the perioperative

AJHP RESIDENTS EDITION

Conclusion
Clarifying reported BLA in the
preoperative setting significantly increased use of first-line antibiotics for
surgical infection prophylaxis. This
intervention highlights an important
role for pharmacists in optimizing
services in the perioperative setting.
Future exploration is needed to mitigate barriers to offering penicillin skin
tests.
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optimization clinic. Offsite allergy
clinics introduced barriers such as
transportation, inconvenience, and
time. The results of this study were used
to support the approval of a new allergy
nurse practitioner position onsite. Part
of the role of this new position is to sustain this BLA clarification intervention
before surgery at patients’ perioperative optimization clinic appointments
and perform penicillin skin tests and/
or oral challenge as indicated.
There are several limitations to the
study. First, there was a limited time to
follow-up of 30 days after surgery, so it
is possible that some clinical outcomes
were unaccounted for after the 30-day
time point. Also, maturation bias, use
of a historical control group, and lack
of randomization are limitations inherent to a quasi-experimental study.
To control for this, the study periods
were chosen to correspond to the
same time period during the year and
a nonequivalent dependent variable
(sequential compression device) was
used to assess for prescribing practice
changes for a similar quality measure,
which nearly all patients received.
Hawthorne effect is possible because
surgeons were aware of the intervention in action. Recall bias is another
limitation because patients could
have misremembered details of an allergy from the past. Additionally, there
was a small sample size. However, our
findings are consistent with past literature and are therefore likely not due to
chance.
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Appendix A—Interview
questions and allergy label
Allergy label

Henry Ford Health System
Pharmacy β-Lactam Allergy
Interview Evaluation
[Patient name] is a [age] y.o. [sex] being
evaluated for β-lactam allergy clarification
prior to procedure.

Subjective:
Allergen

β-Lactam Allergy Clarification
Interview Questions

Reaction

How long ago did the reaction occur?
What was the reaction like?
Was the reaction life threatening?
Was the reaction localized to one
area of the body or full body
reaction?
Was there blistering or peeling of
the skin? Organ involvement?

β-Lactam Allergy History:

How long after taking the antibiotic
did the reaction begin?

5.
6.

Did you require medical treatment for
the reaction? (Antihistamines,
epinephrine, hospitalization, etc?)

7.

1.
2.
3.
4.

What happened when the antibiotic
was stopped?
Why were you taking the antibiotic?
What other medications were you
taking at the time?

8.

9.

Have you taken similar antibiotics?
Have you ever had a penicillin skin
test?

10.
11.
12.
13.

14.

How long ago did the reaction occur?
What was the reaction like?
Was the reaction life threatening?
Was the reaction localized to some area
of the body or full body?
Blistering or peeling of skin?
Involvement of the inside of the mouth,
surface of the eye, or the genital area?
Do you recall whether there was a fever
or involvement of the internal organs
like the liver, kidney, heart, lungs, or
intestines?
Did you require medical treatment for
the reaction? (Antihistamines, epinephrine, hospitalization, etc?)
How long after taking the antibiotic did
the reaction begin?
What happened when the antibiotic
was stopped?
Why were you taking the antibiotic?
What other medications were you
taking at the time?
Have you taken similar (amoxicillin,
Augmentin, Keflex, Omnicef ) or other
antibiotics? If yes, what happened with
those?
Have you ever had a penicillin skin test?

Objective:
Tolerated a β-lactam antibiotic per chart review? [Yes/No]
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Current use of antihistamines: [Yes, but
was told to hold antihistamine at least 1 week
prior to penicillin skin test/No/N/A]

Height and Weight
•
•
•
•

Height:
Actual body weight:
Ideal body weight:
BMI:

Renal Function:
Serum creatinine, date:
Estimated creatinine clearance:
MRSA risk: [Yes. Risk factor: /No]
Assessment: Based on allergy history and
patient interview, the patient [can receive
cephalosporins/cannot receive cephalosporins/cannot receive cephalosporins but
is a candidate for outpatient allergy referral].
Based on MRSA risk factors and procedure, the patient [does/does not] require
vancomycin.

Plan:
•

Recommend [antibiotic name]
IV, dose x 1 dose for preoperative
prophylaxis

OR

•

•

Recommend penicillin allergy evaluation prior to procedure. Outpatient
allergy referral placed.
◦ If patient passes penicillin skin
test, would recommend [antibiotic name] IV x 1 dose for preoperative prophylaxis.
◦ If patient fails penicillin skin test or
is not seen by allergy clinic, would
recommend [antibiotic name] IV x
1 dose for preoperative prophylaxis.
Allergy label updated.
Signature/Title:
Phone number/Beeper:
Date:

Time spent on telephone call and
documentation:
Refer to the HFHS tier 1 guideline for surgical infection prophylaxis (MMC-113)
and management of β-lactam allergy
(MMC-24)
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[Reaction description] occurred [# hours/
days] after taking [β-lactam] when patient was [age]. Reaction resolved after
[describe management]. Per patient, has
taken [β-lactam] in [year/age] with [type of
reaction, if any]. Per chart review, patient has
tolerated [β-lactam] in [month/year]. Patient
[has/has never] had a PCN skin test.

Appendix B—Electronic
medical record documentation
of β-lactam allergy
clarification interview

